Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4379) 4379
Publication (255) 255
Book Review (78) 78
Newsletter (14) 14
Book / eBook (13) 13
Magazine Article (10) 10
Book Chapter (4) 4
Reference (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3711) 3711
female (1837) 1837
male (1768) 1768
adrenergic beta-agonists - therapeutic use (1613) 1613
asthma - drug therapy (1509) 1509
adrenergic beta-agonists - adverse effects (1421) 1421
index medicus (1204) 1204
adult (1196) 1196
adrenergic beta-agonists - administration & dosage (1101) 1101
middle aged (1066) 1066
administration, inhalation (963) 963
asthma (948) 948
animals (782) 782
respiratory system (779) 779
aged (759) 759
adrenergic beta-agonists - pharmacology (701) 701
treatment outcome (593) 593
bronchodilator agents - therapeutic use (580) 580
drug therapy, combination (578) 578
double-blind method (542) 542
adolescent (529) 529
child (519) 519
bronchodilator agents - administration & dosage (514) 514
drug therapy (501) 501
bronchodilator agents - adverse effects (497) 497
pulmonary disease, chronic obstructive - drug therapy (479) 479
pharmacology & pharmacy (478) 478
cardiac & cardiovascular systems (414) 414
asthma - physiopathology (408) 408
albuterol - administration & dosage (407) 407
salmeterol (407) 407
albuterol - therapeutic use (404) 404
medicine, general & internal (383) 383
albuterol - adverse effects (380) 380
dose-response relationship, drug (372) 372
albuterol - analogs & derivatives (371) 371
time factors (366) 366
adrenal cortex hormones - therapeutic use (360) 360
salmeterol xinafoate (359) 359
pregnancy (328) 328
allergy (325) 325
risk factors (315) 315
adrenal cortex hormones - administration & dosage (310) 310
salbutamol (307) 307
anti-asthmatic agents - therapeutic use (303) 303
heart rate - drug effects (272) 272
formoterol fumarate (261) 261
immunology (261) 261
care and treatment (260) 260
copd (258) 258
lung diseases, obstructive (258) 258
albuterol (250) 250
randomized controlled trials as topic (250) 250
formoterol (248) 248
mortality (246) 246
rats (246) 246
asthma - mortality (237) 237
child, preschool (232) 232
nebulizers and vaporizers (231) 231
research (227) 227
chronic obstructive pulmonary disease (226) 226
obstructive pulmonary-disease (226) 226
dosage and administration (225) 225
corticosteroids (223) 223
forced expiratory volume (223) 223
inhaled corticosteroids (223) 223
safety (223) 223
isoproterenol - pharmacology (215) 215
double-blind (207) 207
drug administration schedule (207) 207
health aspects (207) 207
adrenergic beta-2 receptor agonists - administration & dosage (201) 201
anti-asthmatic agents - adverse effects (200) 200
forced expiratory volume - drug effects (200) 200
adrenergic beta agonists (199) 199
anti-asthmatic agents - administration & dosage (199) 199
children (198) 198
drug combinations (197) 197
pulmonary disease, chronic obstructive - physiopathology (197) 197
cross-over studies (193) 193
severity of illness index (188) 188
adrenergic beta-antagonists - therapeutic use (183) 183
therapy (183) 183
analysis (180) 180
ethanolamines - adverse effects (180) 180
risk (180) 180
efficacy (178) 178
ethanolamines - therapeutic use (178) 178
ethanolamines - administration & dosage (177) 177
blood pressure - drug effects (176) 176
adrenergic beta-2 receptor agonists - adverse effects (174) 174
clinical trials as topic (173) 173
critical care medicine (173) 173
abridged index medicus (172) 172
adrenal cortex hormones - adverse effects (172) 172
aged, 80 and over (171) 171
adrenergic beta-2 receptor agonists - therapeutic use (168) 168
pediatrics (167) 167
glucocorticoids - therapeutic use (166) 166
beta-agonists (165) 165
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4045) 4045
German (113) 113
French (83) 83
Spanish (34) 34
Japanese (30) 30
Dutch (19) 19
Italian (15) 15
Swedish (14) 14
Danish (13) 13
Russian (13) 13
Polish (12) 12
Chinese (7) 7
Norwegian (6) 6
Hungarian (4) 4
Romanian (4) 4
Portuguese (3) 3
Bulgarian (2) 2
Lithuanian (2) 2
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Adverse effects of β-agonists
by Sears, Malcolm R
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 12/2002, Volume 110, Issue 6, pp. S322 - S328
Short-acting β-adrenergic receptor agonists have pharmacologically predictable dose-related and potency-related adverse effects, including tachycardia and... 
Airway responsiveness | asthma mortality | cardiotoxicity | β-agonist | inflammation | Inflammation | Cardiotoxicity | Asthma mortality | Genotype | Clinical Trials as Topic | Pharmaceutical Preparations | Bronchodilator Agents - adverse effects | Humans | Adrenergic beta-Agonists - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma
by Chowdhury, Badrul A and Dal Pan, Gerald
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1169 - 1171
The FDA has conducted a comprehensive review of the benefits and risks of using LABAs to treat asthma. Drs. Badrul Chowdhury and Gerald Dal Pan discuss the... 
RISKS | MEDICINE, GENERAL & INTERNAL | Bronchodilator Agents - therapeutic use | Asthma - mortality | United States | Humans | Administration, Inhalation | Drug Approval | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Contraindications | Drug Labeling - legislation & jurisprudence | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination | Delayed-Action Preparations | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Adrenergic beta agonists | Complications and side effects | Reports | Usage | Drug therapy | Asthma | Studies | Confidence intervals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Meta-analysis: Effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths
by Salpeter, Shelley R and Buckley, Nicholas S and Ormiston, Thomas M and Salpeter, Edwin E
Annals of Internal Medicine, ISSN 0003-4819, 06/2006, Volume 144, Issue 12, pp. 904 - 912
Background: Long-acting beta-agonists may increase the risk for fatal and nonfatal asthma exacerbations. Purpose: To assess the risk for severe,... 
MEDICINE, GENERAL & INTERNAL | METERED-DOSE INHALER | TERM TREATMENT | BRONCHIAL RESPONSIVENESS | NEAR-FATAL ASTHMA | DOUBLE-BLIND | PERSISTENT ASTHMA | QUALITY-OF-LIFE | IPRATROPIUM BROMIDE | FORMOTEROL DRY POWDER | SALMETEROL XINAFOATE | Anti-Asthmatic Agents - adverse effects | Asthma - mortality | Recurrence | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Humans | Hospitalization - statistics & numerical data | Male | Ethanolamines - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Child | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Drug Administration Schedule | Risk Factors | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Randomized Controlled Trials as Topic | Anti-Asthmatic Agents - administration & dosage | Albuterol - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Risks of Long-Acting Beta-Agonists in Achieving Asthma Control
by Drazen, Jeffrey M and O'Byrne, Paul M
The New England Journal of Medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1671 - 1672
In early December 2008, the Food and Drug Administration (FDA) held an unusual joint meeting of the Pulmonary–Allergy Drugs Advisory Committee, the Drug Safety... 
FORMOTEROL | MEDICINE, GENERAL & INTERNAL | SAFETY | SALMETEROL | Bronchodilator Agents - therapeutic use | Risk Assessment | Humans | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Asthma - drug therapy | Adrenergic beta-Agonists - adverse effects | Prevention | Adrenergic beta agonists | Complications and side effects | Drug therapy | Salmeterol | Asthma | Respiratory therapy | Clinical trials | Pediatrics | Meetings | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events
by Salpeter, Shelley R., MD, FACP and Wall, Andrew J., MD and Buckley, Nicholas S
American Journal of Medicine, The, ISSN 0002-9343, 2010, Volume 123, Issue 4, pp. 322 - 328.e2
Abstract Background It is unclear whether long-acting β-agonists with concomitant inhaled corticosteroids increase asthma-related intubations and deaths. We... 
Internal Medicine | Inhaled corticosteroids | Intubation | Long-acting beta-agonists | Mortality | Asthma | Meta-analysis | BRONCHODILATOR | RISKS | METAANALYSIS | SAFETY | TOLERANCE | SALMETEROL | MEDICINE, GENERAL & INTERNAL | THERAPY | ANTICHOLINERGIC AGENTS | Anti-Asthmatic Agents - adverse effects | Asthma - mortality | Humans | Administration, Inhalation | Male | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Adrenal Cortex Hormones - adverse effects | Asthma - complications | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Adrenergic beta-Agonists - therapeutic use | Intubation, Intratracheal | Odds Ratio | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cardiovascular effects of β-agonists in patients with asthma and COPD: A meta-analysis
by Salpeter, Shelley R and Ormiston, Thomas M and Salpeter, Edwin E
Chest, ISSN 0012-3692, 2004, Volume 125, Issue 6, pp. 2309 - 2321
Background: beta-Adrenergic agonists exert physiologic effects that are the opposite of those of beta-blockers. beta-Blockers are known to reduce morbidity and... 
Adrenergic β-agonists | Adverse effects | Cardiovascular | Asthma | COPD | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CARDIAC-ARRHYTHMIAS | adrenergic beta-agonists | asthma | cardiovascular | FORMOTEROL DRY POWDER | OBSTRUCTIVE PULMONARY-DISEASE | RISK-FACTOR | RESPIRATORY SYSTEM | ADRENOCEPTOR AGONISTS | adverse effects | PLACEBO-CONTROLLED TRIAL | HEART-RATE | IPRATROPIUM BROMIDE | BRONCHIAL-ASTHMA | Asthma - diagnosis | Pulmonary Disease, Chronic Obstructive - mortality | Severity of Illness Index | Asthma - mortality | Pulmonary Disease, Chronic Obstructive - diagnosis | Drug Administration Schedule | Risk Assessment | Humans | Male | Survival Rate | Cardiovascular System - drug effects | Asthma - drug therapy | Randomized Controlled Trials as Topic | Dose-Response Relationship, Drug | Female | Adrenergic beta-Agonists - therapeutic use | Respiratory Function Tests | Adrenergic beta-Agonists - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
by Lipson, David A and Barnhart, Frank and Brealey, Noushin and Brooks, Jean and Criner, Gerard J and Day, Nicola C and Dransfield, Mark T and Halpin, David M.G and Han, MeiLan K and Jones, C. Elaine and Kilbride, Sally and Lange, Peter and Lomas, David A and Martinez, Fernando J and Singh, Dave and Tabberer, Maggie and Wise, Robert A and Pascoe, Steven J and IMPACT Investigators
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 18, pp. 1671 - 1680
The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
by Calverley, Peter M.A and Anderson, Julie A and Celli, Bartolome and Ferguson, Gary T and Jenkins, Christine and Jones, Paul W and Yates, Julie C and Vestbo, Jørgen and TORCH Investigators and TORCH investigators
The New England Journal of Medicine, ISSN 0028-4793, 02/2007, Volume 356, Issue 8, pp. 775 - 789
This trial involving more than 6000 patients with chronic obstructive pulmonary disease (COPD) compared the effects on all-cause mortality of treatment with an... 
MORTALITY | INHALED CORTICOSTEROIDS | MEDICINE, GENERAL & INTERNAL | Bronchodilator Agents - therapeutic use | Pulmonary Disease, Chronic Obstructive - mortality | Humans | Middle Aged | Male | Risk | Fluticasone | Anti-Inflammatory Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Female | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Double-Blind Method | Administration, Inhalation | Albuterol - analogs & derivatives | Survival Analysis | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Albuterol - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Smoking | Lung diseases, Obstructive | Care and treatment | Dosage and administration | Drug therapy | Salmeterol | Mortality | Chronic obstructive pulmonary disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Pharmacology and therapeutics of bronchodilators
by Cazzola, Mario and Page, Clive P and Calzetta, Luigino and Matera, M. Gabriella
Pharmacological Reviews, ISSN 0031-6997, 2012, Volume 64, Issue 3, pp. 450 - 504
Bronchodilators are central in the treatment of of airways disorders. They are the mainstay of the current management of chronic obstructive pulmonary disease... 
BETA-ADRENOCEPTOR AGONISTS | RANDOMIZED CONTROLLED-TRIALS | OBSTRUCTIVE PULMONARY-DISEASE | METHACHOLINE-INDUCED BRONCHOCONSTRICTION | LONG-ACTING BETA-AGONISTS | ATRIAL-NATRIURETIC-PEPTIDE | INHALED BETA-ADRENOCEPTOR AGONIST | EXERCISE-INDUCED BRONCHOCONSTRICTION | PHARMACOLOGY & PHARMACY | AIRWAY SMOOTH-MUSCLE | GUINEA-PIG TRACHEA | Bronchodilator Agents - therapeutic use | Asthma - metabolism | Xanthines - adverse effects | Humans | Muscarinic Antagonists - adverse effects | Adrenergic beta-Agonists - pharmacology | Bronchodilator Agents - pharmacology | Muscarinic Antagonists - therapeutic use | Xanthines - therapeutic use | Xanthines - pharmacology | Asthma - drug therapy | Drug Discovery | Asthma - genetics | Animals | Muscarinic Antagonists - pharmacology | Adrenergic beta-Agonists - therapeutic use | Pulmonary Disease, Chronic Obstructive - metabolism | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Pulmonary Disease, Chronic Obstructive - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
by Ni Chroinin, Muireann and Lasserson, Toby J and Greenstone, Ilana and Ducharme, Francine M
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2009, Issue 3, pp. CD007949 - CD007949
Background Long-acting beta(2)-agonists (LABA) in combination with inhaled corticosteroids (ICS) are increasingly prescribed in asthmatic children. Objectives... 
MEDICINE, GENERAL & INTERNAL | METERED-DOSE INHALER | FLUTICASONE PROPIONATE-SALMETEROL | COMBINATION THERAPY | PEDIATRIC-PATIENTS | LUNG-FUNCTION | RANDOMIZED CONTROLLED-TRIAL | MILD PERSISTENT ASTHMA | EXHALED NITRIC-OXIDE | SINGLE INHALER | BUDESONIDE/FORMOTEROL MAINTENANCE | Anti-Asthmatic Agents - adverse effects | Beclomethasone - administration & dosage | Formoterol Fumarate | Salmeterol Xinafoate | Humans | Albuterol - analogs & derivatives | Male | Asthma - drug therapy | Ethanolamines - administration & dosage | Adrenal Cortex Hormones - adverse effects | Adolescent | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Beclomethasone - adverse effects | Female | Anti-Asthmatic Agents - administration & dosage | Drug Therapy, Combination | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Safety of long-acting β agonists for the treatment of asthma: clearing the air
by Rodrigo, Gustavo J and Castro-Rodríguez, José A
Thorax, ISSN 0040-6376, 04/2012, Volume 67, Issue 4, pp. 342 - 349
Concerns about the safety of long-acting β2-agonist (LABA) therapy, has led to the appearance of multiple publications and recommendations. This review... 
METAANALYSIS | RESPIRATORY SYSTEM | INHALED CORTICOSTEROIDS | DOUBLE-BLIND | EXACERBATIONS | RISK | DEATH | OUTCOMES | FORMOTEROL DRY POWDER | SALMETEROL | CHILDREN | Anti-Asthmatic Agents - adverse effects | Bronchodilator Agents - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Humans | Administration, Inhalation | Adrenal Cortex Hormones - therapeutic use | Evidence-Based Medicine | Asthma - drug therapy | Adrenal Cortex Hormones - adverse effects | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists — The Influence of Values
by Kramer, Judith M
The New England Journal of Medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1592 - 1595
In December 2008, the FDA reviewed the risks and benefits of inhaled long-acting beta-agonists for the treatment of asthma in adults and children. Dr. Judith... 
MEDICINE, GENERAL & INTERNAL | Bronchodilator Agents - therapeutic use | Risk Assessment | United States | Humans | Administration, Inhalation | Drug Approval | Asthma - drug therapy | Advisory Committees | Drug Labeling | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Delayed-Action Preparations | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Complications and side effects | Usage | Salmeterol | Adrenergic beta agonists | Formoterol | Drug therapy, Combination | Drug therapy | Asthma | Pediatrics | Teenagers | Meetings | Committees | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights